MENLO PARK, Calif., May 14 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing clinical systems for Enabling Regenerative Medicine(TM), announced today that it has been awarded a National Institutes of Health Phase I Small Business Innovation Research (SBIR) Grant entitled "Adult Stem Cell Minimally Invasive Bone Marrow Harvester." The award is to further develop the MarrowMiner(TM) which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for harvesting bone marrow.
"We are pleased to have been awarded this grant," commented Vartan Ghazarossian, PhD, President and CEO of StemCor Systems, Inc. "This SBIR award provides further validation of our scientific and clinical approach, to satisfy the unmet need to easily and effectively obtain marrow-derived cells. The grant will be used to broaden our capabilities regarding the harvest of bone marrow, as well as the processing of stem and progenitor cells it contains, for bone marrow transplantation. Additionally," he explained, "the MarrowMiner System has the potential to improve upon a growing number of therapeutic applications in the field of Regenerative Medicine including cardiovascular, neurologic, diabetic and orthopedic disorders."
About the MarrowMiner
The proprietary MarrowMiner System is designed to rapidly and easily
harvest stem cell-rich bone marrow in a minimally-invasive manner, in the
outpatient setting, and without general anesthesia. This is in contrast to
the current practice of bone marrow aspiration through the insertion of a
large gauge needle into multiple sites of the iliac crest of the hip, which
usually requires general anesthesia, an operating room, and multiple
clinical personnel, and results in marrow highly diluted with peripheral
|SOURCE StemCor Systems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved